{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:35:36Z","timestamp":1769114136198,"version":"3.49.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Emergency Med"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1007\/s11739-007-0026-x","type":"journal-article","created":{"date-parts":[[2007,7,26]],"date-time":"2007-07-26T17:26:36Z","timestamp":1185470796000},"page":"76-83","source":"Crossref","is-referenced-by-count":44,"title":["The coagulation system in endocrine disorders: A narrative review"],"prefix":"10.1007","volume":"2","author":[{"given":"A.","family":"Squizzato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. E. A.","family":"Gerdes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Ageno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. R.","family":"B\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,7,9]]},"reference":[{"key":"26_CR1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0889-8588(18)30675-0","volume":"1","author":"E.S. Orwoll","year":"1987","unstructured":"Orwoll ES, Orwoll RL (1987) Hematologic abnormalities in patients with endocrine and metabolic disorders. Hematol Oncol Clin North Am 1:261\u2013279","journal-title":"Hematol Oncol Clin North Am"},{"key":"26_CR2","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1538-7836.2003.00264.x","volume":"1","author":"F.R. Rosendaal","year":"2003","unstructured":"Rosendaal FR, van Hylckama Vlieg A, Tanis BC, Helmerhorst FM (2003) Estrogens, progestogens and thrombosis. J Thromb Haemost 1:1371\u20131380","journal-title":"J Thromb Haemost"},{"key":"26_CR3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0378-5122(96)01031-6","volume":"24","author":"U.H. Winkler","year":"1996","unstructured":"Winkler UH (1996) Effects of androgens on haemostasis. Maturitas 24:147\u2013155","journal-title":"Maturitas"},{"key":"26_CR4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/00007256-200434080-00003","volume":"34","author":"F. Hartgens","year":"2004","unstructured":"Hartgens F, Kuipers H (2004) Effects of androgenic-anabolic steroids in athletes. Sports Med 34:513\u2013554","journal-title":"Sports Med"},{"key":"26_CR5","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1210\/jc.2005-0765","volume":"90","author":"M.F.R. Sowers","year":"2005","unstructured":"Sowers MFR, Jannausch M, Randolph JF et al (2005) Androgens are associated with hemostatic and inflammatory factors among women at the mid-life. J Clin Endocrinol Metab 90:6064\u20136071","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1360001","volume":"136","author":"L.C. Hofbauer","year":"1997","unstructured":"Hofbauer LC, Heufelder AE (1997) Coagulation disorders in thyroid diseases. Eur J Endocrinol 136:1\u20137","journal-title":"Eur J Endocrinol"},{"key":"26_CR7","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/BF03345311","volume":"27","author":"F. Marongiu","year":"2004","unstructured":"Marongiu F, Cauli C, Mariotti S (2004) Thyroid, hemostasis and thrombosis. J Endocrinol Invest 27:1065\u20131071","journal-title":"J Endocrinol Invest"},{"key":"26_CR8","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1210\/en.2003-1372","volume":"145","author":"C.H. Shih","year":"2004","unstructured":"Shih CH, Chen SL, Yen CC et al (2004) Thyroid hormone receptor dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 145:2804\u20132814","journal-title":"Endocrinology"},{"key":"26_CR9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/pgmj.66.774.280","volume":"66","author":"H.C. Ford","year":"1990","unstructured":"Ford HC, Carter JM (1990) Haemostasis in hypothyroidism. Postgrad Med J 66:280\u2013284","journal-title":"Postgrad Med J"},{"key":"26_CR10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1742-1241.2003.tb10430.x","volume":"57","author":"C. Erem","year":"2003","unstructured":"Erem C, Kavgaci H, Ersoz HO et al (2003) Blood coagulation and fibrinolytic activity in hypothyroidism. Int J Clin Pract 57:78\u201381","journal-title":"Int J Clin Pract"},{"key":"26_CR11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(87)92272-0","volume":"1","author":"R.G. Dalton","year":"1987","unstructured":"Dalton RG, Dewar MS, Savidge GF et al (1987) Hypothyroidism as a cause of acquired von Willebrand\u2019s disease. Lancet 1:1007\u20131009","journal-title":"Lancet"},{"key":"26_CR12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/107602960100700206","volume":"7","author":"J.J. Michiels","year":"2001","unstructured":"Michiels JJ, Schroyens W, Berneman Z, van der Planken M (2001) Acquired von Willebrand syndrome 1 in hypothyroidism: reversal after treatment with thyroxine. Clin Appl Thromb Hemost 7:113\u2013115","journal-title":"Clin Appl Thromb Hemost"},{"key":"26_CR13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-0037-1616250","volume":"93","author":"M. Franchini","year":"2005","unstructured":"Franchini M, Veneri D, Lippi G (2005) Analysis of thyroid hormone status in 131 consecutive individuals with low von Willebrand factor levels. Thromb Haemost 93:392\u2013393","journal-title":"Thromb Haemost"},{"key":"26_CR14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1365-2516.2002.00589.x","volume":"8","author":"M. Franchini","year":"2002","unstructured":"Franchini M, De Gironcoli M, Lippi G et al (2002) Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing thyroid surgery. Haemophilia 8:142\u2013144","journal-title":"Haemophilia"},{"key":"26_CR15","first-page":"1346","volume":"89","author":"M. Franchini","year":"2004","unstructured":"Franchini M, Zugni C, Veneri D et al (2004) High prevalence of acquired von Willebrand\u2019s syndrome in patients with thyroid diseases undergoing thyroid surgery. Haematologica 89:1346","journal-title":"Haematologica"},{"key":"26_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365516309051302","volume":"15","author":"B.O. Egeberg","year":"1963","unstructured":"Egeberg BO (1963) Influence of thyroid function on the blood clotting system. Scand J Clin Lab Invest 15:1\u20137","journal-title":"Scand J Clin Lab Invest"},{"key":"26_CR17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1056\/NEJM196511112732001","volume":"273","author":"J.V. Simone","year":"1965","unstructured":"Simone JV, Abildgaard CF, Schulman I (1965) Blood coagulation in thyroid dysfunction. N Engl J Med 273:1057\u20131061","journal-title":"N Engl J Med"},{"key":"26_CR18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0609.1976.tb01131.x","volume":"16","author":"A. Nordoy","year":"1976","unstructured":"Nordoy A, Vikmo H, Berntsen H (1976) Haemostatic and lipid abnormalities in hypothyroidism. Scand J Haematol 16:154\u2013160","journal-title":"Scand J Haematol"},{"key":"26_CR19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2362.2001.00777.x","volume":"31","author":"B. Muller","year":"2001","unstructured":"Muller B, Tsakiris DA, Roth CB et al (2001) Haemostatic profile in hypothyroidism as potential risk for vascular or thrombotic disease. Eur J Clin Invest 31:131\u2013137","journal-title":"Eur J Clin Invest"},{"key":"26_CR20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0037-1614228","volume":"79","author":"R. Chadaverian","year":"1998","unstructured":"Chadaverian R, Bruckert E, Ankri A et al (1998) Relationship between thyroid hormones and plasma D-dimer levels. Thromb Haemost 79:99\u2013103","journal-title":"Thromb Haemost"},{"key":"26_CR21","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1210\/jcem.86.2.7221","volume":"86","author":"R. Chadaverian","year":"2001","unstructured":"Chadaverian R, Bruckert E, Leenhardt L et al (2001) Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 86:732\u2013737","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF03344016","volume":"25","author":"C. Erem","year":"2002","unstructured":"Erem C, Ersoz H, Karti SS et al (2002) Blood coagulation and fibrinolysis in hyperthyroidism. J Endocrinol Invest 25:345\u2013350","journal-title":"J Endocrinol Invest"},{"key":"26_CR23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/BF03350928","volume":"11","author":"F. Marongiu","year":"1988","unstructured":"Marongiu F, Conti M, Mameli G et al (1988) Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment. J Endocrinol Invest 11:723\u2013725","journal-title":"J Endocrinol Invest"},{"key":"26_CR24","first-page":"43","volume":"58","author":"H.A. Kellet","year":"1986","unstructured":"Kellet HA, Sawers JSA, Boulton FE et al (1986) Problems of anticoagulation with warfarin in hyperthyroidism. Q Med J 58:43\u201351","journal-title":"Q Med J"},{"key":"26_CR25","first-page":"444","volume":"102","author":"J.S. Rogers II","year":"1983","unstructured":"Rogers JS II, Shane SR (1983) Factor VIII activity in normal volunteers receiving oral thyroid hormone. J Lab Clin Med 102:444","journal-title":"J Lab Clin Med"},{"key":"26_CR26","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.STR.0000181772.78492.07","volume":"36","author":"A. Squizzato","year":"2005","unstructured":"Squizzato A, Gerdes VE, Brandjes DP et al (2005) Thyroid diseases and cerebrovascular disease. Stroke 36:2302\u20132310","journal-title":"Stroke"},{"key":"26_CR27","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMra042354","volume":"352","author":"J. Stam","year":"2005","unstructured":"Stam J (2005) Thrombosis of the cerebral veins and sinuses. N Engl J Med 352:1791\u20131798","journal-title":"N Engl J Med"},{"key":"26_CR28","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(00)04172-6","volume":"357","author":"M. Boscaro","year":"2001","unstructured":"Boscaro M, Barzon L, Fallo F, Sonino N (2001) Cushing\u2019s syndrome. Lancet 357:783\u2013791","journal-title":"Lancet"},{"key":"26_CR29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF03346905","volume":"20","author":"A. Brocca La","year":"1997","unstructured":"La Brocca A, Terzolo M, Pia A et al (1997) Recurrent thromboembolism as a hallmark of Cushing\u2019s syndrome. J Endocrinol Invest 20:211\u2013214","journal-title":"J Endocrinol Invest"},{"key":"26_CR30","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/jnnp.2004.057315","volume":"76","author":"S. Yoshimura","year":"2005","unstructured":"Yoshimura S, Ago T, Kitazono T et al (2005) Cerebral sinus thrombosis in a patient with Cushing\u2019s syndrome. J Neurol Neurosurg Psychiatry 76:1182\u20131183","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"26_CR31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.0954-6820.1976.tb06697.x","volume":"199","author":"H.E. Sjoberg","year":"1976","unstructured":"Sjoberg HE, Blomback M, Granberg PO (1976) Thromboembolic complications, heparin treatment and increase in coagulation factors in Cushing\u2019s syndrome. Acta Med Scand 199:95\u201398","journal-title":"Acta Med Scand"},{"key":"26_CR32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-0038-1657887","volume":"54","author":"G.M. Patrassi","year":"1985","unstructured":"Patrassi GM, Dal Bo Zanon R, Boscaro M et al (1985) Further studies on the hypercoagulable state of patients with Cushing\u2019s syndrome. Thromb Haemost 54:518\u2013520","journal-title":"Thromb Haemost"},{"key":"26_CR33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03343697","volume":"23","author":"L.M. Fatti","year":"2000","unstructured":"Fatti LM, Bottasso B, Invitti C et al (2000) Markers of activation of coagulation and fibrinolysis in patients with Cushing\u2019s syndrome. J Endocrinol Invest 23:145\u2013150","journal-title":"J Endocrinol Invest"},{"key":"26_CR34","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00001721-199212000-00013","volume":"3","author":"G.M. Patrassi","year":"1992","unstructured":"Patrassi GM, Sartori MT, Viero ML et al (1992) The fibrinolytic potential in patients with Cushing\u2019s disease: a clue to their hypercoagulable state. Blood Coagul Fibrinolysis 3:789\u2013793","journal-title":"Blood Coagul Fibrinolysis"},{"key":"26_CR35","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1055\/s-2000-8000","volume":"108","author":"B. Ambrosi","year":"2000","unstructured":"Ambrosi B, Sartorio A, Pizzocaro A et al (2000) Evaluation of haemostatic and fibrinolytic markers in patients with Cushing\u2019s syndrome and in patients with adrenal incidentaloma. Exp Clin Endocrinol Diabetes 108:294\u2013298","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"26_CR36","first-page":"3662","volume":"87","author":"M. Boscaro","year":"2002","unstructured":"Boscaro M, Sonino N, Scarda A et al (2002) Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing\u2019s syndrome. J Clin Endocrinol Metab 87:3662\u20133666","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR37","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1055\/s-0037-1613737","volume":"92","author":"L. Feuillet","year":"2004","unstructured":"Feuillet L, Guedj E, Laksiri N et al (2004) Deep vein thrombosis after intravenous immunoglobulins associated with methylprednisolone. Thromb Haemost 92:662\u2013665","journal-title":"Thromb Haemost"},{"key":"26_CR38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0609.1970.tb01890.x","volume":"7","author":"S. Isacson","year":"1970","unstructured":"Isacson S (1970) Effect of prednisolone on the coagulation and fibrinolytic systems. Scand J Haematol 7:212\u2013216","journal-title":"Scand J Haematol"},{"key":"26_CR39","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/1951214a0","volume":"195","author":"S. Ozsoylu","year":"1962","unstructured":"Ozsoylu S, Stauss HS, Diamond LK (1962) Effects of corticosteroids on coagulation of blood. Nature 195:1214\u20131215","journal-title":"Nature"},{"key":"26_CR40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000206946","volume":"68","author":"K.A. Jorgensen","year":"1982","unstructured":"Jorgensen KA, Sorensen P, Freund L (1982) Effect of glucocorticosteroids on some coagulation test. Acta Haematol 68:39\u201343","journal-title":"Acta Haematol"},{"key":"26_CR41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0038-1656320","volume":"68","author":"J.J. Giezen van","year":"1992","unstructured":"van Giezen JJ, Jansen JW (1992) Inhibition of fibrinolytic activity in vivo by dexamethasone is counterbalanced by an inhibition of platelet aggregation. Thromb Haemost 68:69\u201373","journal-title":"Thromb Haemost"},{"key":"26_CR42","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.V60.5.1169.1169","volume":"60","author":"T.W. Muhlfelder","year":"1982","unstructured":"Muhlfelder TW, Niemetz J, Kang S (1982) Glucocorticoids inhibit the generation of leukocyte procoagulant (tissue factor) activity. Blood 60:1169\u20131172","journal-title":"Blood"},{"key":"26_CR43","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0022-3476(68)80107-6","volume":"73","author":"E. Lieberman","year":"1968","unstructured":"Lieberman E, Heuser E, Gilchrist GS et al (1968) Thrombosis, nephrosis, and corticosteroid therapy. J Pediatr 73:320\u2013328","journal-title":"J Pediatr"},{"key":"26_CR44","first-page":"273","volume":"42","author":"R. Matusiewicz","year":"1989","unstructured":"Matusiewicz R, Stempniak M, Lebiedowski K et al (1989) The most frequent complications during long-term corticotherapy. Wiad Lek 42:273\u2013277","journal-title":"Wiad Lek"},{"key":"26_CR45","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.1951.03670270014006","volume":"147","author":"S. Cosgriff","year":"1951","unstructured":"Cosgriff S (1951) Thromboembolic complications associated with ACTH and cortisone therapy. JAMA 147:924\u2013926","journal-title":"JAMA"},{"key":"26_CR46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.thromres.2005.06.006","volume":"118","author":"D.J. Brotman","year":"2005","unstructured":"Brotman DJ, Girod JP, Posch A et al (2005) Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers. Thromb Res 118:247\u2013252","journal-title":"Thromb Res"},{"key":"26_CR47","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1210\/jc.2004-2379","volume":"90","author":"D.J. Brotman","year":"2005","unstructured":"Brotman DJ, Girod JP, Garcia MJ et al (2005) Effects of short-term glucocorticoids on cardiovascular biomarkers. J Clin Endocrinol Metab 90:3202\u20133208","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR48","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000015858","volume":"8","author":"L. Derex","year":"1998","unstructured":"Derex L, Giraud P, Hanss M et al (1998) Spontaneous intracerebral hemorrhage revealing Addison\u2019s disease. Cerebrovasc Dis 8:240\u2013243","journal-title":"Cerebrovasc Dis"},{"key":"26_CR49","first-page":"378","volume":"16","author":"R.A. Asherson","year":"1989","unstructured":"Asherson RA, Hughes GR (1989) Recurrent deep vein thrombosis and Addison\u2019s disease in \u201cprimary\u201d antiphospholipid syndrome. J Rheumatol 16:378\u2013380","journal-title":"J Rheumatol"},{"key":"26_CR50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2265.2000.00903.x","volume":"52","author":"M.A. Satta","year":"2000","unstructured":"Satta MA, Corsello SM, Della Casa S et al (2000) Adrenal insufficiency as the first clinical manifestation of the primary antiphospholipid antibody syndrome. Clin Endocrinol (Oxf) 52:123\u2013126","journal-title":"Clin Endocrinol (Oxf)"},{"key":"26_CR51","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1191\/0961203303lu404oa","volume":"12","author":"G. Espinosa","year":"2003","unstructured":"Espinosa G, Cervera R, Font J, Asherson RA (2003) Adrenal involvement in the antiphospholipid syndrome. Lupus 12:569\u2013572","journal-title":"Lupus"},{"key":"26_CR52","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM199910143411607","volume":"341","author":"M.L. Vance","year":"1999","unstructured":"Vance ML, Mauras N (1999) Growth hormone therapy in adults and children. N Engl J Med 341:1206\u20131216","journal-title":"N Engl J Med"},{"key":"26_CR53","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(98)03356-X","volume":"352","author":"A. Colao","year":"1998","unstructured":"Colao A, Lombardi G (1998) Growth-hormone and prolactin excess. Lancet 352:1455\u20131461","journal-title":"Lancet"},{"key":"26_CR54","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-2000-8145","volume":"108","author":"A. Sartorio","year":"2000","unstructured":"Sartorio A, Cattaneo M, Bucciarelli P et al (2000) Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly. Exp Clin Endocrinol Diabetes 108:486\u2013492","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"26_CR55","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","volume":"336","author":"T. Rosen","year":"1990","unstructured":"Rosen T, Bengtsson BA (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285\u2013288","journal-title":"Lancet"},{"key":"26_CR56","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-0029-1211774","volume":"105","author":"J. Wildbrett","year":"1997","unstructured":"Wildbrett J, Hanefeld M, Fucker K et al (1997) Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: relation to growth hormone levels and insulin-like growth factor I. Exp Clin Endocrinol Diabetes 105:331\u2013335","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"26_CR57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2265.1997.d01-1743.x","volume":"46","author":"K. Landin-Wilhelmsen","year":"1997","unstructured":"Landin-Wilhelmsen K, Tengborn L, Wilhelmsen L, Bengtsson BA (1997) Elevated fibrinogen levels decrease following treatment of acromegaly. Clin Endocrinol (Oxf) 46:69\u201374","journal-title":"Clin Endocrinol (Oxf)"},{"key":"26_CR58","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0038-1650594","volume":"76","author":"J.O. Johansson","year":"1996","unstructured":"Johansson JO, Landin K, Johannsson G et al (1996) Longterm treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults. Thromb Haemost 76:422\u2013428","journal-title":"Thromb Haemost"},{"key":"26_CR59","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1507\/endocrj.51.387","volume":"51","author":"A. Ishizu","year":"2004","unstructured":"Ishizu A, Shimizu C, Tsuji T et al (2004) Peripheral pulmonary embolism related to a thrombus of the inferior vena cava triggering fatal adrenal crisis in Sheehan\u2019s syndrome. Endocrin J 51:387\u2013388","journal-title":"Endocrin J"},{"key":"26_CR60","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1507\/endocrj.52.709","volume":"52","author":"F. Tanriverdi","year":"2005","unstructured":"Tanriverdi F, Gul A, Eryol NK et al (2005) Massive cardiac thrombosis in a patient with Sheehan\u2019s syndrome. Endocrin J 52:709\u2013714","journal-title":"Endocrin J"},{"key":"26_CR61","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1210\/jcem.86.12.8085","volume":"86","author":"H. Wallaschofski","year":"2001","unstructured":"Wallaschofski H, Donn\u00e9 M, Eigenthaler M et al (2001) PRL as a novel potent cofactor for platelet aggregation. J Clin Endocrinol Metab 86:5912\u20135919","journal-title":"J Clin Endocrinol Metab"},{"key":"26_CR62","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-2003-39059","volume":"35","author":"H. Wallaschofski","year":"2003","unstructured":"Wallaschofski H, Kobsar A, Koksch M et al (2003) Prolactin receptor signaling during platelet activation. Horm Metab Res 35:228\u2013235","journal-title":"Horm Metab Res"},{"key":"26_CR63","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1034\/j.1600-0609.2000.065006357.x","volume":"65","author":"R. Kanel von","year":"2000","unstructured":"von Kanel R, Dimsdale JE (2000) Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 65:357\u2013369","journal-title":"Eur J Haematol"},{"key":"26_CR64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1152\/ajplegacy.1903.9.1.35","volume":"9","author":"C.H. Vosburgh","year":"1903","unstructured":"Vosburgh CH, Richards AN (1903) An experimental study of the sugar content and extra vascular coagulation of the blood after administration of adrenalin. Am J Physiol 9:35\u201351","journal-title":"Am J Physiol"},{"key":"26_CR65","first-page":"405","volume":"1","author":"R. Biggs","year":"1947","unstructured":"Biggs R, MacFarlane RG, Philling J (1947) Observations on fibrinolysis. Experimental activity produced by exercise or adrenaline. Lancet 1:405","journal-title":"Lancet"},{"key":"26_CR66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1113\/jphysiol.1961.sp006670","volume":"156","author":"G.I.C. Ingram","year":"1961","unstructured":"Ingram GIC (1961) Increase in antihemophilic globulin activity following infusion of adrenaline. J Physiol 156:217\u2013224","journal-title":"J Physiol"},{"key":"26_CR67","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00001721-199008000-00008","volume":"1","author":"P.J. Grant","year":"1990","unstructured":"Grant PJ (1990) Hormonal regulation of the acute haemostatic response to stress. Blood Coagul Fibrinolysis 1:299\u2013306","journal-title":"Blood Coagul Fibrinolysis"},{"key":"26_CR68","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0002-9343(87)90913-2","volume":"83","author":"B.L. Shulkin","year":"1987","unstructured":"Shulkin BL, Shapiro B, Sisson JC (1987) Pheochromocytoma, polycythemia, and venous thrombosis. Am J Med 83:773\u2013776","journal-title":"Am J Med"},{"key":"26_CR69","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jvs.2005.05.013","volume":"42","author":"S. Stevenson","year":"2005","unstructured":"Stevenson S, Ramani V, Nasim A (2005) Extra-adrenal pheochromocytoma: an unusual cause of deep vein thrombosis. J Vasc Surg 42:570\u2013572","journal-title":"J Vasc Surg"},{"key":"26_CR70","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ndt\/15.5.717","volume":"15","author":"P. Stella","year":"2000","unstructured":"Stella P, Bignotti G, Zerbi S et al (2000) Concurrent pheochromocytoma, diabetes insipidus and cerebral venous thrombosis\u2014a possible unique pathophysiological mechanism. Nephrol Dial Transplant 15:717\u2013718","journal-title":"Nephrol Dial Transplant"},{"key":"26_CR71","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1538-7836.2004.00851.x","volume":"2","author":"M.R. Hoppener","year":"2004","unstructured":"Hoppener MR, Kraaijenhagen RA, Hutten BA et al (2004) Beta-receptor blockade decreases elevated plasma levels of factor VIII:C in patients with deep vein thrombosis. J Thromb Haemost 2:1316\u20131320","journal-title":"J Thromb Haemost"},{"key":"26_CR72","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1172\/JCI117809","volume":"95","author":"D.E. Vaughan","year":"1995","unstructured":"Vaughan DE, Lazos SA, Tong K (1995) Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. J Clin Invest 95:995\u20131001","journal-title":"J Clin Invest"},{"key":"26_CR73","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.HYP.32.6.965","volume":"32","author":"N.J. Brown","year":"1998","unstructured":"Brown NJ, Agirbasli MA, Williams GH et al (1998) Effect of activation and inhibition of the renin angiotensin system on plasma PAI-1 in humans. Hypertension 32:965\u2013971","journal-title":"Hypertension"},{"key":"26_CR74","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ki.1997.20","volume":"51","author":"T. Oikawa","year":"1997","unstructured":"Oikawa T, Freeman M, Lo W et al (1997) Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int 51:164\u2013172","journal-title":"Kidney Int"},{"key":"26_CR75","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199812173392507","volume":"339","author":"A. Ganguly","year":"1998","unstructured":"Ganguly A (1998) Primary aldosteronism. N Engl J Med 339:1828\u20131834","journal-title":"N Engl J Med"},{"key":"26_CR76","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P. Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF et al (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243\u20131248","journal-title":"J Am Coll Cardiol"},{"key":"26_CR77","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","volume":"353","author":"F.R. Rosendaal","year":"1999","unstructured":"Rosendaal FR (1999) Venous thrombosis: a multicausal disease. Lancet 353:1167\u20131173","journal-title":"Lancet"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-007-0026-X.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-007-0026-X\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-007-0026-X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T15:38:06Z","timestamp":1683992286000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-007-0026-X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["26"],"URL":"https:\/\/doi.org\/10.1007\/s11739-007-0026-x","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}